首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1547800

全球全外顯子定序市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Whole Exome Sequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球全外顯子定序市場需求預計將從2023年的4.3002億美元達到近19.3812億美元的市場規模，2024-2032年研究期間複合年成長率為18.21%。

全外顯子定序或外顯子定序是一種次世代定序方法 (NGS)，用於對基因組的蛋白質編碼區域進行定序。全外顯子定序涉及兩個步驟 - 第一步是選擇編碼蛋白質的 DNA 子集，第二步是外顯子 DNA 的定序。測序方法用於臨床診斷和學術研究。它識別出負責蛋白質測序改變的遺傳編碼變異。全基因組定序非常適合癌症研究、了解和識別導致遺傳疾病的遺傳變異以及了解群體遺傳學。

市場動態

由於人們對米勒氏症候群和阿茲海默症等遺傳疾病的認知不斷增強，全球全外顯子定序市場正在擴大。全外顯子定序是全基因組定序的一種經濟高效的替代方案。因此，低成本和高速度是觸發全球全外顯子定序市場的兩個因素。其他推動市場的重要因素包括個人化醫療的日益普及、慢性病病例的增加以及基因組定序研發的不斷成長。此外，技術進步、不斷增加的創新科學應用、現有主要參與者增加投資以及新公司進入市場等因素也在推動市場發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球全外顯子定序市場的各個細分市場進行了包容性評估。全外顯子定序產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

全外顯子定序市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

儀器儀表
耗材
服務

依技術

合成定序
ION 半導體定序
其他

按工作流程

預測序
定序
數據分析

按申請

臨床診斷
藥物發現與開發
個人化藥物
其他

按最終用途

學術及研究機構
醫院和診所
製藥與生物技術公司
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲全外顯子定序市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。全外顯子定序市場的主要參與者包括Thermo Fisher Scientific Inc.、Illumina Inc.、Agilent Technologies Inc.、BGI、PacBio、Oxford Nanopore Technologies Plc.、Azenta US Inc. (Genewiz)、CD Genomics、Novogene Co Ltd、Eurofins Genomics 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按技術分類的市場吸引力分析
- 依工作流程進行市場吸引力分析
- 市場吸引力分析：依應用分類
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球全外顯子定序市場分析：依產品分類

概述（按產品）
歷史和預測數據
按產品分析
儀器儀表
耗材
服務

第 6 章：全球全外顯子定序市場分析：依技術分類

依技術概述
歷史和預測數據
技術分析
合成定序
ION 半導體定序
其他

第 7 章：全球全外顯子定序市場分析：依工作流程

按工作流程概述
歷史和預測數據
按工作流程分析
預測序
定序
數據分析

第 8 章：全球全外顯子定序市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
臨床診斷
藥物發現與開發
個人化藥物
其他

第 9 章：全球全外顯子定序市場分析：依最終用途

按最終用途分類的概述
歷史和預測數據
按最終用途分析
學術及研究機構
醫院和診所
製藥與生物技術公司
其他

第 10 章：全球全外顯子定序市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 11 章：整個外顯子定序公司的競爭格局

全外顯子定序市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Illumina Inc

公司概況
公司收入
產品
最新動態

Agilent Technologies Inc

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

PacBio

公司概況
公司收入
產品
最新動態

Oxford Nanopore Technologies Plc.

公司概況
公司收入
產品
最新動態

Azenta US Inc. (Genewiz)

公司概況
公司收入
產品
最新動態

CD Genomics

公司概況
公司收入
產品
最新動態

Novogene Co Ltd

公司概況
公司收入
產品
最新動態

Eurofins Genomics

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213315

The global demand for Whole Exome Sequencing Market is presumed to reach the market size of nearly USD 1938.12 Million by 2032 from USD 430.02 Million in 2023 with a CAGR of 18.21% under the study period 2024-2032.

Whole Exome Sequencing or Exome Sequencing is a next-generation sequencing method (NGS) used for sequencing of the protein-coding regions of the genome. Whole Exome Sequencing involves two steps - the first step is the selection of the subset of DNA, which encodes proteins, and the second step is the sequencing of the exonic DNA. The sequencing method is used in clinical diagnostics and academic research. It identifies genetic coding variants responsible for alteration in protein sequencing. Whole-genome sequencing is highly applicable in cancer research, understanding and identification of genetic variants causing genetic diseases, and understanding population genetics.

MARKET DYNAMICS

The global Whole Exome Sequencing market is expanding due to increasing awareness about genetic diseases such as Miller's syndrome and Alzheimer's disease. Whole Exome Sequencing is a cost-effective alternative for Whole-genome sequencing. Hence low cost and high speed are the two factors that are triggering the global Whole Exome Sequencing market. The other prominent factors that are driving the market include rising adoption for personalized medicine, growing cases of chronic diseases and growing R & D in genome sequencing. Moreover, factors such as advancement in technology, a growing number of innovative scientific applications, increasing investments by existing key players, and entry of new companies in the market are also propelling the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Exome Sequencing. The growth and trends of Whole Exome Sequencing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Exome Sequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Consumables
Services

By Technology

Sequencing by Synthesis
ION Semiconductor Sequencing
Others

By Workflow

Pre-Sequencing
Sequencing
Data Analysis

By Application

Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Others

By End-use

Academic And Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Exome Sequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Exome Sequencing market include Thermo Fisher Scientific Inc., Illumina Inc, Agilent Technologies Inc, BGI, PacBio, Oxford Nanopore Technologies Plc., Azenta US Inc. (Genewiz), CD Genomics, Novogene Co Ltd, Eurofins Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WHOLE EXOME SEQUENCING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Workflow
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End-use
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Consumables Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data
6.3. Analysis By Technology
6.4. Sequencing by Synthesis Historic and Forecast Sales By Regions
6.5. ION Semiconductor Sequencing Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY WORKFLOW

7.1. Overview By Workflow
7.2. Historical and Forecast Data
7.3. Analysis By Workflow
7.4. Pre-Sequencing Historic and Forecast Sales By Regions
7.5. Sequencing Historic and Forecast Sales By Regions
7.6. Data Analysis Historic and Forecast Sales By Regions

8. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY APPLICATION

8.1. Overview By Application
8.2. Historical and Forecast Data
8.3. Analysis By Application
8.4. Clinical Diagnostics Historic and Forecast Sales By Regions
8.5. Drug Discovery & Development Historic and Forecast Sales By Regions
8.6. Personalized Medicines Historic and Forecast Sales By Regions
8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY END-USE

9.1. Overview By End-use
9.2. Historical and Forecast Data
9.3. Analysis By End-use
9.4. Academic And Research Institutes Historic and Forecast Sales By Regions
9.5. Hospitals & Clinics Historic and Forecast Sales By Regions
9.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
9.7. Others Historic and Forecast Sales By Regions

10. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE WHOLE EXOME SEQUENCING COMPANIES

11.1. Whole Exome Sequencing Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF WHOLE EXOME SEQUENCING INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fisher Scientific Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Illumina Inc
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Agilent Technologies Inc
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. BGI
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. PacBio
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Oxford Nanopore Technologies Plc.
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Azenta US Inc. (Genewiz)
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. CD Genomics
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Novogene Co Ltd
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Eurofins Genomics
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments